NCT02624570 · Expanded access
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Overall registry status No longer available
Conditions Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
Delaware Valley sites
- University of Pennsylvania Cancer Center University of Pen/Abr Canc ctr · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory